Medical Oddities: Friends, Family… and Faster Aging?
-
By
-
Teraya Smith
-
March 18, 2026
-
6 min
By
Teraya Smith
March 18, 2026
The approval expands subcutaneous use across newly diagnosed and previously treated multiple myeloma.
July 10, 2026
The annual provisional report summarizes changes in mortality rates, demographic patterns, and leading causes of death during 2025.
July 13, 2026
KEYNOTE-B15/EV-304 demonstrated statistically significant improvements in event-free and overall survival with perioperative pembrolizumab plus enfortumab vedotin-ejfv compared with neoadjuvant gemcitabine plus cisplatin.
July 10, 2026